Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)
1 University College London, Moorfields Eye Hospital, London, United Kingdom.
2 Auckland District Health Board, Auckland, New Zealand.
3 Oxford Eye Hospital, Nuffield Laboratory of Ophthalmology, Oxford University hospitals NHS Trust, Oxford, United Kingdom.
4 Save Sight Institute, The University of Sydney, Sydney, Australia.
5 University College London, Moorfields Eye Hospital, London, United Kingdom; Bnai Zion Medical Center, Technion, Israel Institute of Technology, Haifa, Israel. Electronic address: oren.tomkins@b-zion.org.il.
6 Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel.
7 Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
8 Linköping University, Östergötland County, Sweden.